CUGH 2015: Plenary Speakers

2015 CUGH Global Health Conference Plenary Speakers
 

TS01.0 Plenary I: The Technology Revolution in Genetics: Relevance to Global Health

Please view plenary speaker bios, session recordings and presentation slides. Presentation slides were only made available when speakers provided to CUGH for public viewing.
 
Moderator: Robert Finberg, Chair, Department of Medicine, University of Massachusetts Medical School

Dr. Robert Finberg is the Richard Haidak Professor and Chair of Medicine at the University of Massachusetts Medical School. He is a clinician-scientist with expertise in infectious diseases including viral evolution and pathogenesis and immune responses to viruses and bacteria. He has published over 200 peer reviewed papers on the pathogenesis of viral and bacterial infections, and is an expert on host responses to infections and infections in immunocompromised hosts.
 

 
Speaker: Dyann Wirth, Richard Pearson Strong Professor and Chair, Immunology and Infectious Diseases, Harvard School of Public Health

Professor Dyann Wirth has been a major leader in the area of malaria research. Her work has provided completely new insight into how the malaria parasite has evolved, specifically in the areas of population biology, drug resistance and antigenicity. The Wirth laboratory blends the scientific environments of the Harvard School of Public Health, the Broad Institute, and collaborators from around the globe to create a unique malaria research and training network that brings together scientists with expertise in molecular biology, genetics, genomics, population genetics, chemistry, cell biology, epidemiology, computational biology, biostatistics, and leading clinicians in infectious diseases and pathology. Using this approach, the Wirth group is working to understand the mechanisms of drug resistance in Plasmodium falciparum, the major human malaria parasite. Leveraging the genomic tools of the human genomic project, the group has applied state of the art technologies and novel approaches to better understand the fundamental biology of the malaria parasite and mechanisms of drug resistance. Professor Wirth’s research activities are made possible through collaborative research partnerships with investigators, universities, and clinical centers in Africa, Asia, Central and South America.

 
Speaker: Craig Venter, Co-Founder, Executive Chairman and Co-Chief Scientist, Synthetic Genomics, Inc.

J. CRAIG VENTER, Ph.D., is a biologist renowned for his contributions in sequencing the first draft human genome in 2001, the first complete diploid human genome in 2007 and construction of the first synthetic bacterial cell in 2010. He is a co-founder and CEO of Human Longevity Inc (HLI), a privately held genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span. He is also founder, chairman and CEO of the J. Craig Venter Institute (JCVI) and a co-founder, chairman and co-chief scientist of Synthetic Genomics Inc (SGI), a  privately held company focused on developing products and solutions using synthetic genomic technologies. He and his teams are focused on a variety of projects and programs including: synthetic genomic research and the application of these advances to develop new vaccines and food and nutritional products, new biofuels and biochemicals; continued analysis of the human genome including the human microbiome, and discovering and understanding genetic diversity in the world's oceans. Dr. Venter is a recipient of the 2008 National Medal of Science and is a member of the National Academy of Sciences.  He is the author of Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life (Viking, 2013) and A Life Decoded: My Genome: My Life (Viking, 2007).

 

TS02.0 Plenary II: One Health: Targeting Emerging Infectious Diseases and Food Security

 
Moderator: Deborah Kochevar, Dean and Henry and Lois Foster Professor, Tufts University

Deborah Kochevar, DVM, PhD, DACVCP is Dean and Henry and Lois Foster Professor at the Cummings School of Veterinary Medicine, Tufts University. She is a diplomat and past president of the American College of Veterinary Clinical Pharmacology and is active in the American Veterinary Medical Association, having chaired its Council on Education and the Educational Commission for Foreign Veterinary Graduates. She served as president and chair of the Board of Directors of the Association of American Veterinary Medical Colleges until July 2013. Dr. Kochevar has published in peer-reviewed research and teaching journals and garnered extramural funding for her work. She has won college, university and national level teaching awards. Dr. Kochevar supports national and international efforts to implement One Health curricula as a strategy for prevention of emerging pandemic threats and promotion of health. Cummings School has been engaged in USAID-funded One Health studies, including through RESPOND and One Health Workforce grants.

 
Speaker: Jonna Mazet, Professor and Director, UC Davis One Health Institute

Jonna Mazet, DVM, MPVM, PhD, is a Professor of Epidemiology and Disease Ecology and Director of the One Health Institute in the UC Davis School of Veterinary Medicine where she focuses on global health problem solving, especially for emerging infectious disease and conservation challenges. Dr. Mazet is active in international One Health research programs, especially disease transmission among wildlife, domestic animals, and people and the ecological drivers for disease emergence. Currently, she is the Global Director of a $175 million viral emergence early warning project, named PREDICT, that has been developed with the US Agency for International Development’s (USAID) Emerging Pandemic Threats Program. She has recently been elected to the National Academies’ Institute of Medicine in recognition of her successful and innovative approach to emerging environmental and global health threats.
View Presentation Slides

 
Speaker: Gebisa Ejeta, Distinguished Professor, Purdue University

Gebisa Ejeta is Distinguished Professor of Plant Breeding & Genetics and International Agriculture and serves as Executive Director of the Center for Global Food Security at Purdue University.  Gebisa has been a member of the faculty of Purdue University since 1984. His career has been devoted to education, research, and international development. He has made contributions in human and institutional capacity building, in technology development and transfer, as well as in advocacy for science, technology, and innovations that change livelihoods. Professor Ejeta has served in advisory roles to several international development agencies. He currently serves on the boards of the Chicago Council for Global Affairs’ Global Agricultural Development Initiative (GADI), the National Academy of Sciences Board on Agriculture and Natural Resources (BANR), and the United Nations Secretary General Ban Ki Moon’s Scientific Advisory Board (SAB). Professor Ejeta has served the United States Government in several capacities, including as Special Advisor to the USAID Administrator Dr. Rajiv Shah, as Science Envoy of the U.S. State Department, before being appointed by President Obama as member of the Board for International Food and Agricultural Development (BIFAD) in 2010. The 2009 World Food Prize Laureate and a recipient of a national medal of honor from the President of Ethiopia, Ejeta is a Fellow of the African Academy of Sciences, Fellow of the American Association for the Advancement of Sciences, Fellow of the American Society of Agronomy, and Fellow of the Crop Science Society of America.

 

TS03.0 Plenary III: Debate 1 – Investment in the SDG framework should be in strengthening health systems, not specific diseases.

 
Moderator: Thomas Quinn, Director, Johns Hopkins University Center for Global Health

Dr. Thomas Quinn is Professor of Medicine and Pathology in the Johns Hopkins School of Medicine and Professor of International Health, Epidemiology, and Molecular Microbiology and Immunology in The Johns Hopkins School of Public Health, and Professor of Nursing in the Johns Hopkins School of Nursing.  In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health.
Dr. Quinn has been involved in clinical, virological and epidemiologic investigations of HIV/AIDS in 29 countries, with current projects in Uganda, Zimbabwe, Tanzania, India, China, and Thailand. He was one of the first scientists to identify the AIDS epidemic and its cause HIV, in Africa in the early phases of the global pandemic.  His investigations have involved the study of the epidemiologic, virologic, immunologic features of HIV infection in Africa, the Caribbean, South America and Asia.  His research interests have involved laboratory investigations that have helped define the biological factors involved in sexual and perinatal transmission of HIV, the natural history of HIV infections in developing countries, and the characterization of unique strains of HIV-1 infection.
He serves as advisor/consultant on HIV and STDs to the Office of the Global AIDS Coordinator, UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases.  He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the Infectious Diseases Society of America.

 
Speaker: Olusoji Adeyi, Director, Health, Nutrition and Population Global Practice, The World Bank

Olusoji Adeyi, MD, MBA, DrPH, is the Director of the Health, Nutrition and Population Global Practice at the World Bank Group. Dr. Adeyi was founding Director of the Affordable Medicines Facility-malaria (AMFm) at the Global Fund to Fight AIDS, Tuberculosis and Malaria. He has extensive experience in policies, strategies and programs for health systems, service delivery and disease control at the global, regional and country levels.

 
Speaker: Sandro Galea, Dean, School of Public Health, Boston University

Dr Galea is a physician and an epidemiologist.   He is Dean and Professor at the Boston University School of Public Health.  Prior to his appointment at Boston University, Dr Galea served as the Anna Cheskis Gelman and Murray Charles Gelman Professor and Chair of the Department of Epidemiology at the Columbia University Mailman School of Public Health where he launched several new educational initiatives and substantially increased its focus on six core areas: chronic, infectious, injury, lifecourse, psychiatric/neurological, and social epidemiology.  He previously held academic and leadership positions at the University of Michigan and at the New York Academy of Medicine.
In his own scholarship, Dr Galea is centrally interested in the social production of health of urban populations, with a focus on the causes of brain disorders, particularly common mood-anxiety disorders and substance abuse.  He has published over 500 scientific journal articles, 50 chapters and commentaries, and 9 books and his research has been featured extensively in current periodicals and newspapers. His latest book, co-authored with Dr Katherine Keyes, is an epidemiology textbook, Epidemiology Matters: a new introduction to methodological foundations.
Dr Galea has a medical degree from the University of Toronto, and graduate degrees from Harvard University and Columbia University.  He was named one of TIME magazine’s epidemiology innovators in 2006. He is past-president of the Society for Epidemiologic Research and an elected member of the American Epidemiological Society and of the Institute of Medicine of the National Academies of Science.
View Presentation Slides

TS04.0 Plenary IV: The Drivers of Non-Communicable Diseases

 
Moderator: Margaret Bentley, Associate Dean for Global Health, University of North Carolina - Chapel Hill

Dr. Margareata Bentley is the Carla Smith Chamblee Distinguished Professor of Global Nutrition and the Associate Dean for Global Health in the Gillings School of Global Public Health at the University of North Carolina, Chapel HIll.  She eceived her MA and PhD degrees in Medical Anthropology from the University of Connecticut.  From 1985-98 she was on faculty in International Health at the Bloomberg School of Public Health, Johns Hopkins University.  Since 1998 she has been on faculty at the University of North Carolina, where she has held several leadership roles.  Dr. Bentley’s research focuses on women and infant's nutrition, infant and young child feeding, behavioral research on sexually transmitted diseases, HIV, and community-based interventions for nutrition and health.  She has particular expertise in the use of qualitative methods for intervention design and evaluation.  She has particular expertise in qualitative research methods and the application of these for program development and evaluation. She is a Fellow of the Society for Applied Anthropology.  In 2005 she was named Paul G. Rogers Ambassador for Global Health and is the founding Chair of the Board of Directors of the Triangle Global Health Consortium.  She is a member of the Board of Directors of the Consortium for Universities in Global Health.

 
Speaker: David Relman, Professor of Medicine, and of Microbiology & Immunology, Stanford University

David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. He is also Co-Director of the Center for International Security and Cooperation and Senior Fellow at the Freeman Spogli Institute for International Studies at Stanford.
Relman’s research focus for the past 15 years has been the human indigenous microbiota, and in particular, the nature and mechanisms of variation in patterns of microbial diversity and function. Key issues addressed by this research include microbial community assembly, stability and resilience. Previous research focused on strategies for identifying previously-unrecognized microbial agents of disease. He has advised the U.S. Government on matters pertaining to emerging infectious diseases, human-microbe interactions, and biosecurity. He is Chair of the Forum on Microbial Threats at the Institute of Medicine, and served as President of the Infectious Diseases Society of America.
Dr. Relman received an S.B. (Biology) from MIT (1977), M.D. from Harvard Medical School (1982), completed clinical training at Massachusetts General Hospital, served as a postdoctoral fellow and joined the faculty at Stanford in 1994. He received an NIH Director’s Pioneer Award in 2006 and an NIH Transformative Research Award in 2013. He is a Fellow of the American Academy of Microbiology, Fellow of the American Association for Advancement of Science, and Member of the Institute of Medicine.

 
Speaker: Susan Shurin, Senior Adviser, Center for Global Health, National Cancer Institute, National Institutes of Health

Susan B. Shurin, M.D., is Senior Adviser with the Office of Global Health at the National Cancer Institute.  She served as deputy director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) from February, 2006 through June, 2014.
View Presentation Slides

 

TS05.0 Plenary V: Improvement Science: From Theory to Practice

 
Moderator: Pierre Barker, Senior Vice President, Institute for Healthcare Improvement

Pierre M. Barker, MD, Senior Vice President, Institute for Healthcare Improvement (IHI), is responsible for IHI’s large-scale health systems improvement initiatives outside the USA. Working closely with partners in government and the non-governmental sector, IHI has an expanding portfolio of work to improve the reliability and scale-up of effective health programs in Europe, Africa, Middle East, Australasia, and Latin America. In addition to advising governments and large organizations on quality strategies, IHI uses the science of improvement to promote improved outcomes in the areas of patient safety, population health, patient-centered care, and cost of care. Dr. Barker attended medical school in South Africa and trained in pediatrics in the UK and US. Before joining IHI, he was Medical Director of University of North Carolina (UNC) Children’s Hospital clinics and was responsible for leading health-system-wide initiatives on improving access to care and chronic disease management. A renowned authority on improving health systems, Dr. Barker initially served at IHI as in-country Director of IHI’s South Africa Projects and then as head of IHI programs in low- and middle-income countries. He retains a position of Clinical Professor of Pediatrics in the Maternal and Child Health Department at Gillings School of Global Public Health at UNC Chapel Hill. He also advises the World Health Organization on health systems strengthening, redesign of HIV care, and infant feeding guidelines.

 
Speaker: Atul Gawande, Executive Director, Ariadne Labs

 

 
Speaker: Nancy Edwards, Scientific Director, Canadian Institutes of Health Research

Nancy Edwards is a Distinguished Professor, University of Ottawa, and Full Professor in the School of Nursing.  She was appointed Scientific Director, Institute of Population and Public Health, Canadian Institutes of Health Research in July, 2008.  Dr. Edwards obtained her undergraduate nursing degree from the University of Windsor and completed graduate studies in epidemiology at McMaster University and McGill University. She is a fellow of the Canadian Academy of Health Sciences and has been awarded two honorary doctorate degrees.
Dr. Edwards’ clinical and research interests are in the fields of public and population health. She has conducted health services, policy and clinical research both nationally and internationally. Her research has informed the design and evaluation of complex multi-level and multi-strategy community health programs. Her work in global health has spanned four continents where she has led both development-oriented and research-focused projects.
Dr. Edwards has contributed to over 180 peer-reviewed and 125 technical publications and presented over 400 conference papers. She has served on numerous advisory committees.  Most recently these include the international expert advisory committee for Public Health Research in Horizon 2020 (EU Commission); advisory councils for the Public Health Agency of Canada National Collaborating Centres and the Canadian Population Health Initiative; and a joint technical task group of the National Research Council that is reviewing building code recommendations for ramps, stairs, handrails and guards.

TS06.0 Plenary VI: Big Problems – Big Ideas

 
Moderator: Keith Martin, Executive Director, The Consortium of Universities for Global Health (CUGH)

Hon. Dr. Keith Martin MD, PC.  Executive Director  Consortium of Universities for Global Health,  2012- present. Member of Parliament, Canada. 1993-2011. Portfolios: Parl. Secretary Defense. Shadow Ministerial Portfolios in Foreign Affairs, Health, International Development. Founder and Chair: Parliamentary Conservation Caucus 2007-2011, Canada Aid 2006-2011. Creator and Host: TV Series, Beyond Politics 1997-2001.
Currently:
Board Member, Global Health Council
Board Member, Jane Goodall Institute. (USA)
Editorial Board Member:  Annals of Global Health
Ambassador for the Global Sepsis Alliance
Advisory Board Member: International Cancer Expert Corps.
Physician.

 
Speaker: Julio Frenk, Dean of the Faculty, Harvard School of Public Health

Julio Frenk, MD, MPH, PhD, is Dean of the Faculty at the Harvard T.H. Chan School of Public Health. He is also the T & G Angelopoulos Professor of Public Health and International Development, a joint position with the John F. Kennedy School of Government at Harvard.
Dr. Frenk served as the Minister of Health of Mexico from 2000 to 2006, where he pursued an ambitious agenda to reform the nation’s health system, with an emphasis on redressing social inequality. He is perhaps best known for his work in introducing a program of universal coverage, known as Seguro Popular, which has expanded access to comprehensive health services for 52 million previously uninsured Mexicans. He was the founding director-general of the National Institute of Public Health of Mexico and has also held leadership positions at the Mexican Health Foundation, the World Health Organization, the Bill and Melinda Gates Foundation, and the Carso Health Institute.
In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers across the world think about health.”

 
Speaker: Jeremy Farrar, Director, Wellcome Trust

Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in health by supporting the brightest minds.   Before joining the Trust he was Director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were in infectious diseases, tropical health and emerging infections.  He has contributed to 500 peer-reviewed scientific papers, and served on several World Health Organization advisory committees.
Jeremy was appointed OBE in 2005 for services to Tropical Medicine, and he has been awarded the Memorial Medal and Ho Chi Minh City Medal from the Government of Vietnam, Frederick Murgatroyd Prize for Tropical Medicine by the Royal College Physicians and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a Fellow of the Academy of Medical Sciences.
Jeremy is married with three children, he loves all sport and walking in the Alps.

 
Speaker: Victor Dzau, President, Institute of Medicine (IOM)

Victor Dzau is President of the Institute of Medicine. He is Chancellor Emeritus at Duke University and was Chairman at Harvard Medical School and Stanford University.
 Dr. Dzau has made significant impact through seminal research in cardiovascular medicine and genetics and leadership in health care innovation. In his role as a leader, Dr. Dzau has led efforts to improve healthcare, including the development of the Duke Translational Medicine Institute and the Duke Institute for Health Innovation.
Dr. Dzau’s passion is in eliminating health inequity. In 2001, he created with Dr. Paul Farmer and Jim Kim the Division of Global Health Equity at the Brigham and Women’s Hospital. At Duke, he led development of the Duke Global Health Institute and Duke-National University of Singapore Graduate Medical School.
As one of the world’s preeminent health leaders, Dr. Dzau advises governments, corporations, and universities worldwide. He served as Chair of the NIH Cardiovascular Disease Advisory Committee. He is a member of the Board of the Singapore Health System and Hamad Medical Corporation, Qatar. He was on the Board of Health Governors of the World Economic Forum and chaired its Global Agenda Council on Personalized and Precision Medicine.
Among his honors are the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Distinguished Scientist Award from the American Heart Association, and the Henry Freisen International Prize. He received the Singapore National Day Public Service Medal.  He is a member of the American and European Academys of Arts and Sciences.

 
Speaker: Esther Duflo, Co –Director, Abdul Latif Jameel Poverty Action Lab, Massachusetts Institute of Technology

Esther Duflo is the Abdul Latif Jameel Professor of Poverty Alleviation and Development Economics in the Department of Economics at the Massachusetts Institute of Technology and a co-founder and co-director of the Abdul Latif Jameel Poverty Action Lab (J-PAL). In her research, she seeks to understand the economic lives of the poor, with the aim to help design and evaluate social policies. She has worked on health, education, financial inclusion, environment and governance.
Professor Esther Duflo’s first degrees were in history and economics from Ecole Normale Superieure, Paris. She subsequently received a Ph.D. in Economics from MIT in 1999.
Duflo has received numerous academic honors and prizes including the Infosys Prize (2014), the David N. Kershaw Award (2011), a John Bates Clark Medal (2010), and a MacArthur “Genius Grant” Fellowship (2009).  With Abhijit Banerjee, she wrote "Poor Economics: A Radical Rethinking of the Way to Fight Global Poverty", which won the Financial Times and Goldman Sachs Business Book of the Year Award in 2011 and has been translated into 17 languages.
Duflo is a member of the President’s Global Development Council and she is a Founding Editor of the "American Economic Journal: Applied Economics".

 
Speaker: Paul Farmer, Co-Founder, Partners in Health

Paul Farmer, MD, PhD, is Kolokotrones University Professor and Chair of the Department of Global Health and Social Medicine at Harvard Medical School, Chief of the Division of Global Health Equity at Brigham and Women’s Hospital in Boston, and co-founder of Partners In Health. He also serves as UN Special Adviser to the Secretary-General on Community Based Medicine and Lessons from Haiti. Dr. Farmer and his colleagues have pioneered novel, community-based treatment strategies that demonstrate the delivery of high-quality health care in resource-poor settings. He has written extensively on health, human rights, and the consequences of social inequality, and he is a member of the Institute of Medicine of the National Academy of Sciences and of the American Academy of Arts and Sciences.

 
Speaker: Glenda Gray, President and CEO, South African Medical Research Council

Glenda Gray, MBBCH, FCPaeds (SA), DSc (honoris causa), an NRF A rated scientist, President of the South African Medical Research Council. Gray, a Paediatrician, trained in South Africa and co-founded and led the internationally renowned Perinatal HIV Research Unit, based at the Chris Hani Baragwanath Hospital in Soweto. She has expertise in PMTCT, HIV vaccines and microbicides. She is the Co-PI of the HIV Vaccine Trials Network and Director of the HVTN International Programs. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of PMTCT of HIV-1. She is a member of the Academy of Science of SA, and chairs their standing committee on health. She is a member of the Institute of Medicine, of the National Academies, and serves on their Global Health Board.
Gray was awarded the IAPAC “Hero of Medicine” award for work done in the field of HIV treatment in children and adults. In 2009, James McIntyre and Gray received the N’Galy-Mann lectureship in recognition of their HIV research contribution in RSA.  In June 2012 she received a DSc (honoris causa) from the Simon Fraser University, for her work in the field of PMTCT. She has been admitted into the American Academy of Microbiology. In 2013 she received the country’s highest honour, the Order of Mapungubwe, granted by the president of RSA for achievements in the international area which have served South Africa’s interest. In 2013, she received the EDCTP Outstanding African Scientist award.

 
Speaker: Christopher Wilson, Director, Global Health Discovery & Translational Sciences Program, Bill and Melinda Gates Foundation

Chris Wilson, Director of the Global Health Discovery & Translational Sciences program, leads a team that targets fundamental scientific and technological advances in global health that could lead to new ways to prevent, treat, and diagnose disease. Prior to joining the Gates Foundation in 2009, he was a member of the faculty at the University of Washington from 1979-2009, where he served as head of the Division of Infectious Diseases, Immunology and Rheumatology, Department of Pediatrics from 1989-1999, then as Chairman of the Department of Immunology and head of the graduate program in immunology from 1999-2009.
He has served on a number of national advisory panels, including the Institute of Medicine Vaccine Safety Review Committee (2001-2004) and the Advisory Council, National Institute of Child Health and Human Development, National Institutes of Health (NIH). He is a member of the Advisory Committee to the Director, NIH and the Advisory Council of the National Institute of Allergy & Infections Diseases (as of November 2013). He is an elected fellow of the American Association for the Advancement of Science.
Wilson received a bachelor’s degree from the University of California, Irvine and a medical degree from UCLA. He trained in pediatrics at Boston Children’s Hospital /Harvard Medical School, served in the US Public Health Service, and then was a post-doctoral fellow in infectious diseases while performing immunology research at Stanford University.

TS07.0 Plenary VII: Epidemic Ebola: Looking Back, Lessons Learned, Looking Ahead

 
Moderator: Michele Barry, Senior Associate Dean for Global Health, Stanford University

Michele Barry, MD, FACP is Senior Associate Dean for Global Health and the Director of the Center for Global Health Innovation at Stanford University.  As one of the founders of the Yale/Stanford Johnson and Johnson Global Health Scholar Award program, she has sent over 1000 physicians overseas to underserved areas to help strengthen health infrastructure in low resource settings.  As a past President of the American Society of Tropical Medicine and Hygiene (ASTMH), she led an educational initiative in tropical medicine and travelers health which culminated in diploma courses both in the U.S. and overseas, as well as a U.S. certification exam.  Dr. Barry is an elected member of the Institute of Medicine (IOM) and National Academy of Sciences. She currently sits on the Board of Directors of the Consortium of Universities in Global Health (CUGH), the Foundation for Advancement of International Medical Education and Research (FAIMER) and the Advisory Board for the NIH-Fogarty Center. She is also the recipient of the Ben Kean Medal given every three years by the ASTMH for excellence in teaching tropical diseases.

 
Moderator and Speaker: Peter Piot, Director & Professor of Global Health, London School of Hygiene and Tropical Medicine

Peter Piot is the Director of the London School of Hygiene & Tropical Medicine and a Professor of Global Health. He trained as a clinician and microbiologist and was part of the international team that discovered the Ebola virus in Zaire in 1976. He was the founding Executive Director of UNAIDS and Under Secretary-General of the UN from 1995 until 2008.  He was a professor of microbiology and global health at the Institute of Tropical Medicine Antwerp, the University of Nairobi and Imperial College London and was a Senior Fellow at the Bill & Melinda Gates Foundation.
He is a Fellow of the Academy of Medical Sciences and the Royal College of Physicians and was elected a foreign member of the Institute of Medicine of the US National Academy of Sciences, and is also an elected member of the Académie Nationale de Médicine of France and of the Royal Academy of Medicine of Belgium.
He has received numerous scientific and civic awards including an honorary doctorate from 7 universities, the Thomas Parran Award, the Nelson Mandela Award for Health and Human Rights, and the Frank A Calderon Prize in Public Health.  He was knighted as a baron in 1995, and awarded a CMG in 2009. In 2013 he was the laureate of the Hideyo Noguchi Africa Prize for Medical Research and in 2014 he received the Prince Mahidol Award for Public Health. He has published over 550 scientific articles and 16 books, including his memior 'No Time to Lose'.
View Presentation Slides

 
Speaker: Jean-Jacques Muyembe Tamfum, Director, Institut National de Recherche Biomédicale (INRB)

Professor JJ.Muyembe-Tamfum, MD,PhD,  is a leading medical scientist in Democratic Republic of Congo (DRC) in the field of viral emerging and reemerging diseases.
Medical doctor, University of Lovanium, Leopoldville (Kinshasa) in 1969 and  PhD in Virology, University of Louvain, Belgium in 1973.He was appointed full professor of Microbiology at the  Kinshasa University medical school in 1976.
He was appointed dean of the Faculty of Kinshasa University Medical   school in 1976-1981 and Director General of the National Institute for Biomedical Research(INRB) since 1998 and chief of the WHO/National Polio and Measles laboratories in charge of biological surveillance of Acute Flaccid Paralysis(Poliomyelitis) and measles/yellow fever for both DRC and Republic of Congo(Brazzaville)..
His main scientific field of interest is Ebola hemorrhagic fever (clinical, laboratory and epidemiological aspects including control measures) since 1976 when he was the first scientist to investigate the mysterious disease (Ebola) with a high fatality rate in Yambuku catholic mission. Since then, he was involved in several Ebola outbreaks in DRC(7) and neighboring countries (Republic of Congo and Gabon) as the chairman of the international scientific and technical coordination committee.
He serves as a scientific advisor to WHO in several Ebola expert groups in 2014-15. He is author and co author of more than 100 scientific papers in peer reviewed journals.

 
Speaker: Beth P. Bell, Director, National Center for Emerging and Zoonotic Infectious Diseases, CDC

Beth P. Bell, MD, MPH, FIDSA, has served as Director of the National Center for Emerging and Zoonotic Infectious Diseases at the Centers for Disease Control and Prevention (CDC) since 2010. Priority focus areas include food safety, antimicrobial resistance, healthcare associated infections, vectorborne diseases including dengue and chikungunya, and newly emerging pathogens both domestically and globally.
Dr. Bell joined CDC in 1992 as an Epidemic Intelligence Service (EIS) officer assigned to the Washington State Department of Health, lead officer in the investigation of the seminal outbreak of E. coli O157:H7 infections from contaminated hamburgers. After EIS, she joined the Hepatitis Branch in the Division of Viral and Rickettsial Diseases. She made numerous contributions in the epidemiology and prevention of viral hepatitis, including spearheading development of U.S. policy for the use of hepatitis A vaccine and assisting in efforts to expand use of hepatitis B vaccination globally. Dr. Bell also served in leadership roles during CDC responses to several major public health events, including the 2001 anthrax attacks, Hurricane Katrina, and the 2009 H1N1 influenza pandemic.
She received B.A. from Brown University, M.D. from Yale University, and a M.P.H. from the University of Rochester School of Medicine. She is a fellow of IDSA, the American Academy of Family Medicine, and the American Academy of Preventive Medicine. The author or co-author of more than 125 scientific publications, Dr. Bell has received numerous awards for her work including the Alexander Langmuir Prize and the Iain Hardy Award.

 
Speaker: Larry Madoff, Editor, ProMed Mail

Larry Madoff, MD. Editor, ProMED-mail.  Dr. Madoff is an academic infectious disease physician specializing in the epidemiology of emerging pathogens, bacterial pathogenesis, and international health.  He is a Professor of Medicine at the University of Massachusetts Medical School and Lecturer on Medicine at Harvard Medical School.  Dr. Madoff serves as Director of Epidemiology and Immunization and Deputy State Epidemiologist for the Massachusetts Department of Public Health.  Dr. Madoff has directed ProMED, the Program for Monitoring Emerging Diseases, since 2002. He is a member of the American Society for Microbiology, the International Society for Infectious Diseases, past President of the U.S. Lancefield Streptococcal Research Society, a Fellow of the Infectious Diseases Society of America and a Fellow of the American College of Physicians. A graduate of Yale College and Tufts Medical School, he performed his Internal Medicine Residency at New York Hospital-Cornell Medical Center and his Infectious Disease Fellowship at the Harvard Medical School-Longwood program.  He is the author of over 100 scientific and medical publications on topics involving infectious diseases and microbiology.

 
Speaker: Oyewale NMI. Tomori, President, Nigerian Academy of Science

Tomori is currently, President, Nigerian Academy of Science. He was pioneer Vice-Chancellor at the Redeemer’s University, Nigeria. He is a recipient of the NNOM, Nigeria’s highest award for academic and intellectual attainment.  At the University of Ibadan, Nigeria, as Professor of Virology, he led research into study of viral infections, and elucidated the properties of Orungo virus, registered with the ICVT.  In 1981, he received the USPHS Certificate for contribution to Lassa Fever Research. At the WHO Africa Region, as Regional Virologist from 1994-2004, he set up the African Regional Polio Laboratory Network, which provided laboratory diagnostic support for polio eradication, and became the forerunner of regional diagnostic laboratory networks for other diseases. He has been involved in the investigations of outbreaks of VHFs (YF, EVD, etc) infections in many African countries. Tomori serves on several national and international advisory bodies including, Nigeria Expert Review Committee (ERC) on Poliomyelitis Eradication and Routine Immunization; and as member of the US-IOM Committee on Sustainable global surveillance of zoonotic diseases; US-IOM Committee on identifying and prioritizing new preventive vaccines for development; WHO Strategic Advisory Group of Experts (SAGE); Co-Chairman, ASADI/USNAS/NASAC Study Team on Country Ownership of Africa’s Development, SAGE Working Group on Ebola.

 
Speaker: Nahid Bhadelia, Director of Infection Control, Boston Medical Center and National Emerging Infectious Diseases laboratory, Boston University

Dr. Nahid Bhadelia, MD, MA is an infectious diseases physician, Assistant Professor at the Boston University School of Medicine and the Director of Infection Control at National Emerging Infectious Diseases Laboratory (NEIDL) at Boston University (BU). Her specialization is in infection control issues related to emerging pathogens and highly communicable infectious diseases. She is the director of the medical response program for BU’s biosafety level 4 laboratories at the NEIDL, one of 6 such programs in the US.
Aside from her clinical training in infectious diseases, she has masters degree in international affairs and a background in health and human security with a focus on the impact of pandemics on macro level health indicators and community security.  She has served as a front line physician providing care to Ebola patients in Sierra Leone with World Health Organization. She is a Senior Policy and Technical Advisor to Partners in Health and most recently served as an interim clinical director of PIH’s Ebola response program in Sierra Leone. She has also been an instructor for the CDC/FEMA healthcare worker preparedness course for the Ebola Response.

 
Speaker: Larry Gostin, Faculty Director, O’Neill Institute for National & Global Health Law

Lawrence O. Gostin is University Professor (Georgetown University’s highest academic rank), Founding O’Neill Chair in Global Health Law, and Director of the O’Neill Institute for National and Global Health Law. Prof. Gostin holds international professorial appointments at Oxford University, University of Witwatersrand, (South Africa), and Melbourne University. He sits on Board, Consortium of Universities for Global Health.
Prof. Gostin is the Director of the World Health Organization Collaborating Center on Public Health Law & Human Rights, and serves on expert WHO advisory committees on WHO reform, mental health, International Health Regulations, and Pandemic Influenza Preparedness. Prof. Gostin holds editorial appointments throughout the world., notably Health Law Editor and Columnist, Journal of the American Medical Association.
Prof. Gostin holds honorary doctoral degrees from the State University of New York, Cardiff University, Sydney University, and the Royal Institute of Public Health. He is a Member of the Institute of Medicine/National Academy of Sciences,, Council of Foreign Relations, and Hastings Center. The IOM awarded Prof. Gostin the Yarmolinsky Medal for distinguished service to further its mission of science and health. He received the Public Health Law Association’s Distinguished Lifetime Achievement Award.
Prof. Gostin received the Delbridge Memorial Award from the National Consumer Council (United Kingdom) for the person “who has most influenced Parliament and government to act for the welfare of society.” His latest book is Global Health Law (Harvard University Press, 2014).